Yong VW - Search Results

1

Pilot study of minocycline in relapsing-remitting multiple sclerosis.

Zhang Y, Metz LM, Yong VW, Bell RB, Yeung M, Patry DG, Mitchell JR. Zhang Y, et al. Among authors: yong vw. Can J Neurol Sci. 2008 May;35(2):185-91. doi: 10.1017/s0317167100008611. Can J Neurol Sci. 2008. PMID: 18574932 Clinical Trial.

2

Matrix metalloproteinases and diseases of the CNS.

Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. Yong VW, et al. Trends Neurosci. 1998 Feb;21(2):75-80. doi: 10.1016/s0166-2236(97)01169-7. Trends Neurosci. 1998. PMID: 9498303 Review.

3

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.

Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW. Brundula V, et al. Among authors: yong vw. Brain. 2002 Jun;125(Pt 6):1297-308. doi: 10.1093/brain/awf133. Brain. 2002. PMID: 12023318

4

Cytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosis.

Chabot S, Yong FP, Le DM, Metz LM, Myles T, Yong VW. Chabot S, et al. Among authors: yong fp, yong vw. Mult Scler. 2002 Aug;8(4):299-306. doi: 10.1191/1352458502ms810oa. Mult Scler. 2002. PMID: 12166500

5

Prospects for neuroprotection in multiple sclerosis.

Yong VW. Yong VW. Front Biosci. 2004 Jan 1;9:864-72. doi: 10.2741/1276. Front Biosci. 2004. PMID: 14766415 Review.

6

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

Metz LM, Zhang Y, Yeung M, Patry DG, Bell RB, Stoian CA, Yong VW, Patten SB, Duquette P, Antel JP, Mitchell JR. Metz LM, et al. Among authors: yong vw. Ann Neurol. 2004 May;55(5):756. doi: 10.1002/ana.20111. Ann Neurol. 2004. PMID: 15122721 No abstract available.

7

The promise of minocycline in neurology.

Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM. Yong VW, et al. Lancet Neurol. 2004 Dec;3(12):744-51. doi: 10.1016/S1474-4422(04)00937-8. Lancet Neurol. 2004. PMID: 15556807 Review.

8

Additive effect of the combination of glatiramer acetate and minocycline in a model of MS.

Giuliani F, Metz LM, Wilson T, Fan Y, Bar-Or A, Yong VW. Giuliani F, et al. Among authors: yong vw. J Neuroimmunol. 2005 Jan;158(1-2):213-21. doi: 10.1016/j.jneuroim.2004.09.006. J Neuroimmunol. 2005. PMID: 15589056

9

Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.

Giuliani F, Fu SA, Metz LM, Yong VW. Giuliani F, et al. Among authors: yong vw. J Neuroimmunol. 2005 Aug;165(1-2):83-91. doi: 10.1016/j.jneuroim.2005.04.020. J Neuroimmunol. 2005. PMID: 15958276

10

The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.

Zhou Y, Zhang J, Liu Q, Bell R, Muruve DA, Forsyth P, Arcellana-Panlilio M, Robbins S, Yong VW. Zhou Y, et al. Among authors: yong vw. Carcinogenesis. 2005 Dec;26(12):2058-68. doi: 10.1093/carcin/bgi182. Epub 2005 Jul 20. Carcinogenesis. 2005. PMID: 16033775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters